24/7 FSE Hotline +1-800-465-6442 · [email protected] EN | ES | FR-CA
Clinical applications

Where Hologic runs hospitals and care networks worldwide.

Regional deployment depends on local registration, importer pathways, and model-specific intended use. Use the tabs below as a planning map, not a clearance guarantee.

Hospital laboratories, imaging centers, and home-care agencies under FDA 510(k) pathways where applicable. Typical diligence includes GPO contracting, UDI readiness, post-market surveillance (PMS) expectations, and HIPAA-aware support intake.

  • Care settings: tertiary hospitals, community hospitals, reference labs, home health agencies
  • Documents often requested: 510(k) summary, IFU, service schedule, cybersecurity notes, QMS evidence
  • Constraint: clearance status is model- and revision-specific; brochure language is not a site authorization

CE marked under MDR 2017/745 or IVDR 2017/746 for covered families, with GDPR-conformant inquiry handling and Notified Body technical documentation on request.

  • Care settings: hospital labs, imaging networks, outpatient diagnostics, home-care providers
  • Documents often requested: DoC, CER excerpts, PMS plan summary, UDI labeling evidence
  • Constraint: MDR / IVDR class and Notified Body scope must match the SKU under review

UKCA pathways and NHS / private provider frameworks. Confirm current UK-specific labeling and importer status before deployment.

  • Care settings: NHS trusts, private hospitals, regional laboratory networks
  • Documents often requested: UKCA / legacy CE evidence, MHRA registration, local IFU pack
  • Constraint: post-Brexit labeling and responsible-person details can lag brochure packs

PMDA-approved configurations via authorized importer channels. Local language IFU and service training remain part of acceptance planning.

  • Care settings: university hospitals, community hospitals, commercial laboratories
  • Documents often requested: Japanese IFU, importer authorization, service training syllabus
  • Constraint: configuration and software revision must match the registered dossier

NMPA-registered SKUs for applicable product families. Regional service coverage and language support should be confirmed for Tier 2/3 hospital networks.

  • Care settings: Tier 1–3 hospitals, regional reference labs, selected home-care programs
  • Documents often requested: NMPA registration certificate, Chinese labeling, local service matrix
  • Constraint: unregistered accessories or software options cannot be assumed from global catalogs

Hospital and laboratory deployments across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with country-by-country registration checks.

  • Care settings: national hospitals, private hospital groups, public health laboratories
  • Documents often requested: country registration letter, importer license, bilingual IFU where required
  • Constraint: ASEAN mutual recognition is incomplete; plan per-country timelines of 3–12 months
Method trade-offs

Two decisions that reshape a Hologic deployment brief

Neither side is universally correct. Capture the operating constraint first, then choose the architecture.

Central laboratory vs. POCT / near-patient testing

Central lab: Higher throughput envelopes (often 600–2,000 tests/hour class comparisons), tighter coefficient-of-variation control, consolidated CAPA and LIS exception handling, but longer turnaround for remote wards.

POCT / near-patient: Faster clinical decisions at bedside or clinic, lower specimen transport risk, but more operator variability, denser QC logistics, and more fragmented HL7 FHIR messaging paths.

Hologic planning starts from specimen arrival profile and reporting SLA, not from a preference for either architecture.

Single-use consumables vs. reusable / reprocessed pathways

Single-use: Predictable sterility assurance level (SAL) assumptions, lower reprocessing liability, simpler ASC turnover — at higher per-case cost and waste volume.

Reusable with validated reprocessing: Lower lifecycle cost and waste when AAMI ST91 / ISO 17664 evidence is complete, but infection-control committees will require documented Spaulding classification and operator training.

For home-care lifts, beds, and selected accessories, Hologic documents which pathway applies so infection control and sustainability teams review the same evidence pack.

Installed-base distribution (planning view)

  1. US
    60%
  2. EU
    22%
  3. APAC
    14%
  4. RoW
    4%

Distribution figures are illustrative planning shares for site architecture conversations, not audited sales disclosures.

Looking to deploy in a new region?

We support FDA / CE MDR / UKCA / PMDA / NMPA registration assistance conversations and map local service coverage before capital approval.

Please enter your name.
Please enter a valid work email.
Please enter your organization.
Please select an inquiry path.
Please describe the requirement.
Consent is required to submit this form.